Vertex and Kymera Therapeutics establish strategic collaboration
Vertex and Kymera Therapeutics announced the two companies have entered into a four-year strategic research and development collaboration to advance small molecule protein degraders against multiple targets. The collaboration will leverage Kymera’s expertise in targeted protein degradation. May 15, 2019